// App-Quantinova.ai

: Successful Treatment with Eculizumab in a Patient with Antiphospholipid Syndrome Presenting with a Thrombotic Storm

Researchers

Presenter

  • J. Nauseef

Principal Investigators

  • H. Lim

  • J. Saab

  • C. Magro

  • M. DeSancho

Medical Centers

  • New York Presbyterian Hosp/Weill Med College, Medicine ‐ Hematology & Oncology, New York, United States

  • Weill Cornell Medicine/Memorial Sloan Kettering Cancer Center, Pathology, New York, United States

  • New York Presbyterian Hosp/Weill Med College, Pathology and Laboratory Medicine ‐ Dermatopathology, New York, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Autoimmune hemolytic anemia

  • Extrahepatic portal vein obstruction

  • Antiphospholipid syndrome

  • Thrombocytopenia

  • Venous thrombosis

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Eculizumab

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved